DTE
43
5
ESS
62
-3
BEN
50
9
SBUX
37
-2
IRM
41
3
MDLZ
32
-4
TMO
42
-6
OMC
50
-16
IR
63
-3
KHC
9
-4
EQT
51
-3
CTAS
53
-3
V
64
-2
GRMN
67
-4
SHW
62
-6
MMM
35
-5
CCI
30
-11
BXP
49
-3
KSS
39
-7
CNX
73
-3
DTE
43
5
ESS
62
-3
BEN
50
9
SBUX
37
-2
IRM
41
3
MDLZ
32
-4
TMO
42
-6
OMC
50
-16
IR
63
-3
KHC
9
-4
EQT
51
-3
CTAS
53
-3
V
64
-2
GRMN
67
-4
SHW
62
-6
MMM
35
-5
CCI
30
-11
BXP
49
-3
KSS
39
-7
CNX
73
-3
Financhill
Back

Atlas Arteria Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
13

MAQAF
Atlas Arteria

Last Price:
3.09
Seasonality Move:
2.66%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
13
Atlas Arteria (MAQAF) is a Sell

Is Atlas Arteria a Buy, Sell or Hold?

  • The current Atlas Arteria [MAQAF] share price is $3.09. The Score for MAQAF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • MAQAF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MAQAF Stock Price Chart

What is Atlas Arteria's stock price today?

  • The Atlas Arteria share price today is $3.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAQAF is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MAQAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 39.34 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.13 - 3.37) Sell
Bollinger Bands (100): (3.12 - 3.5) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MAQAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.29 Sell
20-day SMA: 3.24 Sell
50-day SMA: 3.2 Sell
200-day SMA: 3.4 Sell
8-day EMA: 3.25 Sell
20-day EMA: 3.25 Sell
50-day EMA: 3.25 Sell
200-day EMA: 3.42 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Atlas Arteria Earnings Growth & MAQAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Atlas Arteria Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):